Musical hallucinations in cerebrovascular disease.
brain lesion
cerebrovascular disease
hearing impairment
musical hallucinations
stroke
Journal
Postepy psychiatrii neurologii
ISSN: 2720-5371
Titre abrégé: Postep Psychiatr Neurol
Pays: Poland
ID NLM: 9434378
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
09
03
2021
accepted:
07
05
2021
medline:
1
9
2021
pubmed:
1
9
2021
entrez:
21
04
2023
Statut:
ppublish
Résumé
Musical hallucinations (MH) are a subset of complex auditory hallucinations in which individuals perceive music in the absence of an external auditory stimulus. It is a rare phenomenon, first described by Ballinger in 1846, with diverse presentations from familiar childhood melodies to a simple pitch which evolved into the harmonies Robert Schumann incorporated in his sole Violin Concerto. This uncommon phenomenon has diverse etiologies, including psychiatric and neurological backgrounds, which guide its classification and methods of treatment. The pathophysiological basis of MH remains understood incompletely, potentially resulting from lesions anywhere along the auditory pathway, from the external auditory canal to the auditory cortex. The strong association between MH and hearing impairment has led researchers to hypothesize that MH represent a "release phenomenon," in which sensory deprivation, eliminating the afferent input to the auditory sensory network, instigates spontaneous activity within a system - comparable to the Charles Bonnet syndrome, in which visual impairment precipitates the development of visual hallucinations (so called auditory Charles Bonnet syndrome), and phantom limb syndrome, in which amputees experience sensations in a limb that is not no longer there. In this paper, we report on six cases of MH in patients with cerebrovascular disease, who presented to the neurology department at the Poznan University of Medical Sciences from 2015 to 2018. We discuss the findings of computed tomography and magnetic resonance imaging of six cases of MH in patients with cerebrovascular disease, and the treatment leading to its resolution. We briefly review the literature on MH in patients with cerebrovascular diseases, discussing their suggested pathophysiology, clinical presentations and response to medical treatment.
Identifiants
pubmed: 37082771
doi: 10.5114/ppn.2021.110759
pii: 45628
pmc: PMC9881628
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
177-182Informations de copyright
Copyright © 2021 Institute of Psychiatry and Neurology.
Déclaration de conflit d'intérêts
Absent.
Références
Front Psychol. 2015 Jun 16;6:814
pubmed: 26136708
Brain. 2006 Oct;129(Pt 10):2533-53
pubmed: 16845129
Nat Rev Dis Primers. 2015 Apr 23;1:15002
pubmed: 27189141
Neurology. 2000 Aug 8;55(3):454-5
pubmed: 10932294
Prog Neurobiol. 2017 Jun;153:1-17
pubmed: 28408150
J Psychiatry Neurosci. 2003 Nov;28(6):432-49
pubmed: 14631455
Br J Psychiatry. 1990 Feb;156:188-94
pubmed: 2180526
Brain. 2015 Dec;138(Pt 12):3793-802
pubmed: 26446167
Am J Psychiatry. 1986 Sep;143(9):1088-97
pubmed: 2875662
J Neurol Sci. 2004 Dec 15;227(1):55-65
pubmed: 15546592
Brain. 2000 Oct;123 ( Pt 10):2065-76
pubmed: 11004124
J Neurol. 2013 Oct;260(10):2678-80
pubmed: 24057151
Behav Neurol. 2005;16(4):211-6
pubmed: 16518011